Table 1.
Baseline patient characteristics of early diffuse recurrence (EDR) patients.
| Characteristic | S-TACE (n=48) | TACE (n=128) | P value |
|---|---|---|---|
| Sex | 0.789 | ||
| Male Female |
42(87.5) 6(12.5) |
110(85.9) 18(14.1) |
|
| Age(y) | 0.565 | ||
| Median±SD Range |
55.0±11.7 26–77 |
56.0±11.9 22–78 |
|
| Cause of HCC | 0.514 | ||
| HBV HCV Alcohol Other |
39(81.3) 4(8.3) 1(2.1) 4(8.3) |
109(85.2) 9(7.1) 3(2.3) 7(5.4) |
|
| Liver cirrhosis | 33(68.8) | 101(78.9) | 0.160 |
| ALB(g/L) | 0.124 | ||
| Median±SD Range |
36.0±6.7 27-73 |
37.0±6.3 24-66 |
|
| TB (umol/L) | 0.618 | ||
| Median± SD Range |
25.5±6.3 11–44 |
27.0±13.4 5–90 |
|
| AFP(ng/ml) | 0.053 | ||
| ≥400 <400 |
21(43.8) 27(56.3) |
78(60.9) 50(39.1) |
|
| HBV-DNA ≥100 <100 |
31(64.6) 17(35.4) |
53(41.4) 75(58.6) |
0.051 |
| ECOG | 0.891 | ||
| 0 1 |
42(87.5) 6(12.5) |
111(86.7) 17(13.3) |
|
| Child-Pugh | 0.508 | ||
| A B |
41(85.4) 7(14.6) |
114(89.1) 14(10.9) |
|
| Maximal tumor diameter(cm) | 0.181 | ||
| Median ± SD Range |
5.0±2.6 2.0-13.0 |
4.0±2.9 1.0-13.0 |
Except where indicated, data are numbers of patients. Data in parentheses are percentages and were calculated by using the total number of patients in each group as the denominator.